Patient acceptance of prefilled disposable vaginal applicator.
M E LePage, D Brown, J Wells
Index: Am. J. Obstet. Gynecol. 158(4) , 1006-8, (1988)
Full Text: HTML
Abstract
Patient acceptance of a new, compact, prefilled disposable vaginal applicator was tested in an open study in which 2% butoconazole cream was used for the treatment of vulvovaginal candidiasis. Twenty nonpregnant patients with clinical signs and symptoms of candidiasis and microscopic identification of Candida in wet smear were treated for 3 days and then asked to rate the convenience of and their acceptance of the prefilled vaginal applicator. No adverse events were reported. All of the patients readily accepted the idea of a prefilled applicator and judged the shape and surface of the test applicator to be comfortable and the applicator to be easily inserted. Patients judged this applicator to be the most convenient and least messy when compared with other commercially available, reusable, or prefilled disposable applicators.
Related Compounds
Related Articles:
1990-01-01
[Diagn. Microbiol. Infect. Dis. 13(1) , 31-5, (1990)]
1988-04-01
[Am. J. Obstet. Gynecol. 158(4) , 1011-3, (1988)]
Control of Candida albicans vaginitis in mice by short-duration butoconazole treatment in situ.
1993-01-01
[Mycoses 36(11-12) , 379-84, (1993)]
1994-01-01
[Clin. Ther. 16(6) , 930-4, (1994)]
1988-01-01
[J. Int. Med. Res. 16(5) , 367-75, (1988)]